Lumentum Holdings Inc. — FY2022 Form 10-K
Reporting period: Fiscal year ended July 2, 2022 (52 weeks). The request metadata says “2021 Q4,” but this filing reports FY2022 annual results, not a standalone Q4 report. FY2021 ended July 3, 2021 and included 53 weeks.
Business context
Lumentum supplies optical communications products and commercial lasers. Its two reportable segments are Optical Communications (OpComms) and Lasers. OpComms represented 88.7% of FY2022 revenue; Lasers represented 11.3%. Sales are highly international, with 89.8% of revenue shipped outside the United States.
Financial performance and liquidity
| Metric | FY2022 | FY2021 | Change |
|---|---|---|---|
| Revenue | $1,712.6 million | $1,742.8 million | Down 1.7% |
| Gross profit / margin | $788.6 million / 46.0% | $783.1 million / 44.9% | Margin up 1.1 percentage points |
| Operating income | $303.3 million | $527.0 million | Down 42.5% |
| Net income | $198.9 million | $397.3 million | Down 49.9% |
| Diluted EPS | $2.68 | $5.07 | Down 47.1% |
| Cash from operations | $459.3 million | $738.7 million | Down $279.4 million |
- OpComms revenue declined 6.3% to $1,518.5 million, reflecting component shortages that constrained Telecom and Datacom shipments and lower average selling prices in Consumer and Industrial.
- Lasers revenue rose 59.0% to $194.1 million as demand for kilowatt-class fiber lasers recovered with industrial production.
- Segment gross margins were 51.4% for OpComms and 52.6% for Lasers. Consolidated gross margin improved despite $14.0 million of broker-sourced component costs.
- Operating cash flow was $459.3 million. Capital expenditures were $91.2 million. Cash and cash equivalents were $1,290.2 million, and short-term investments were $1,258.8 million at year-end.
- Total liabilities were $2,287.2 million and stockholders’ equity was $1,875.0 million. Convertible notes had $2,359.1 million of aggregate principal outstanding: $450 million due 2024, $1,050 million due 2026, and $861 million due 2028. The 2024 notes’ $409.9 million carrying amount was classified as current because holders could convert them.
- Inventory rose to $250.1 million from $196.4 million, partly due to higher-cost component procurement and supply-chain buffers.
Changes, outlook, and notable items
- FY2021 results included a $207.5 million net gain from Coherent’s termination fee, materially boosting prior-year operating income and net income. This makes the reported year-over-year profit decline larger than the underlying comparison alone might suggest.
- Management expected component supply constraints to continue into at least the second half of FY2023 in the business discussion; the MD&A section separately said challenges were expected at least through the second quarter of FY2023. The filing therefore gives differing timeframes for the anticipated constraint period.
- Management said cash, cash equivalents, and operating cash flows should cover liquidity and capital spending needs for at least 12 months. It planned continued investment in R&D and expected R&D spending to increase in absolute dollars in future quarters. No specific revenue or earnings guidance was provided.
- After year-end, Lumentum completed the NeoPhotonics acquisition on August 3, 2022 for $867.3 million in cash, plus $50.0 million of previously funded loans included in purchase consideration. On August 15, 2022, it completed another acquisition focused on telecom and datacenter components. These transactions were not reflected in FY2022 operating results.
- FY2022 also included issuance of $861.0 million of 2028 convertible notes and $543.9 million of share repurchases. The board expanded its repurchase authorization to $1.0 billion through May 2024. Lumentum does not expect to pay dividends in the foreseeable future.
- Material risks include semiconductor and logistics shortages, reliance on a few customers and suppliers, export controls and China trade restrictions, pricing pressure, COVID-related disruption, foreign-exchange volatility, and execution and integration risks from acquisitions. Apple accounted for 28.7% of FY2022 revenue and Ciena for 12.6%.
- The audit opinion on the financial statements was unqualified; the auditor also gave an unqualified opinion on internal control over financial reporting. Inventory valuation was identified as a critical audit matter because it depends on demand forecasts and product-life assumptions. The filing reports ongoing Oclaro merger litigation and litigation challenging the NeoPhotonics merger; management said ordinary-course claims were not currently expected to have a material adverse effect, but outcomes remain uncertain.
Important facts for investors to verify
- Whether supply availability, lead times, and broker-sourced component costs improved after year-end, and the resulting effect on shipments, inventory, and gross margin.
- Underlying OpComms demand and customer concentration, especially Apple and Ciena, alongside the trajectory of Lasers demand.
- Post-acquisition cash use, financing, purchase accounting, integration costs, and whether the NeoPhotonics and August 2022 acquisitions deliver expected benefits.
- Convertible-note cash repayment or dilution exposure, particularly the 2024 maturity and conversion status, as well as remaining repurchase authorization and capital allocation priorities.
- Resolution and potential financial exposure from pending merger litigation, tax audits and unrecognized tax benefits, and other contingencies.